Phathom Pharmaceuticals, Inc. (PHAT) Dividend History

Phathom Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing treatments for gastrointestinal diseases. The company aims to address unmet medical needs through innovative therapies, with a particular emphasis on conditions such as acid-related disorders.

100 Campus Drive,, Florham Park, NJ, 07932
Phone: (877) 742-8466
Website: https://www.phathompharma.com

Dividend History

Phathom Pharmaceuticals, Inc. currently does not pay dividends

Company News

  • Phathom Pharmaceuticals, a biopharmaceutical company, announced the appointment of Ted Schroeder, a seasoned biopharma leader, to its Board of Directors. Schroeder's deep operational and commercial expertise is expected to be an important asset as Phathom continues to unlock the full potential of its lead product, VOQUEZNA.

    GlobeNewswire Inc.
  • The article discusses the top 3 most-shorted stocks in August, including Beyond Meat (BYND), Phathom Pharmaceuticals (PHAT), and Groupon (GRPN). It analyzes the short interest, financial performance, and market outlook for each company.

    Investing.com
    Featured Companies: BYND GRPN
  • Stay up to date with the latest financial news! Listen to the Wall Street Breakfast podcast on Seeking Alpha, iTunes, and Spotify.

    Seeking Alpha
  • Phathom Pharmaceuticals (PHAT) delivered earnings and revenue surprises of 0.70% and 30.73%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

    Zacks Investment Research
    Featured Companies: AKYA
  • U.S. stocks were mostly lower, with the Nasdaq Composite falling more than 200 points on Tuesday. Shares of Walmart Inc. (NYSE: WMT) rose in today’s session after the company reported better-than-expected fourth-quarter financial results. Walmart reported fourth-quarter FY24 net sales growth of 5.7% year-over-year to $173.39 billion, beating the consensus of $170.71 billion. Adjusted EPS was $1.80, beating the consensus of $1.65. The board approved an annual cash dividend for fiscal year 2025 of 83 cents per share on a post-stock split basis or $2.49 per share on a pre-split basis, approximately a 9% increase from the $2.28 per share paid for the last fiscal year. Walmart shares gained 4.9% to $178.66 on Tuesday. Here are some other big stocks recording gains in today’s session. Iovance Biotherapeutics, ...

    Benzinga
    Featured Companies: AWI COF IOVA OMI TDS WMT
Page data last updated 07/23/2025 06:16:44 UTC